Emergent Biosolutions Inc

EBSNYSE · USD
6.06USD+0.21 (+3.59%)
1015

Emergent Biosolutions Inc (EBS) Wheel Strategy

EBS wheel strategy scan found 7 cash-secured put setups on the previous trading day. Probability of expiring worthless is above 50%. Annualized returns reach up to 169.0%.

Read more

Running a EBS wheel strategy lets you generate consistent premium income on Emergent Biosolutions Inc while setting your own entry and exit prices on the underlying. Emergent Biosolutions Inc's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own EBS, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best EBS wheel strategy setups in real time.

The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on EBS, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable EBS wheel from a losing one.

Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emerging infectious diseases; travel health; and emerging health crises and acute/emergency care. It offers BioThrax, an anthrax vaccine; ACAM2000, a smallpox vaccine; Botulism Antitoxin Heptavalent to treat botulinum disease; vaccinia immune globulin intravenous that addresses complications from smallpox vaccine; raxibacumab for the treatment and prophylaxis of inhalational anthrax; Anthrasil to for inhalational anthrax; reactive skin decontamination lotion kits; and Trobigard, a combination drug-device auto injector product candidate; and Trobigard, a combination drug-device auto injector product candidate.

The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the EBS wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your EBS wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.

Nov 20, 20266.00$0.35$0.50-0.351877%57.7%169.0%148
Dec 18, 20266.00$0.50$0.65-0.354677%50.6%86.0%14
Dec 18, 20265.00$0.20$0.30-0.194677%69.1%47.6%41
Mar 19, 20274.00$0.05$0.53-0.1513777%66.7%35.0%21
Jan 15, 20275.00$0.25$0.35-0.207477%62.1%34.5%147
Mar 19, 20275.00$0.50$0.60-0.2213777%53.5%32.0%82
Jan 15, 20274.00$0.05$0.13-0.087477%78.1%15.4%32

As of Nov 5, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $2,243. Ending soon.See the Early Bird Black Friday deal →